Canada markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
4.5350+0.1150 (+2.60%)
As of 09:33AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.19B
Enterprise Value 1.18B
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)8.32
Price/Book (mrq)1.62
Enterprise Value/Revenue 8.77
Enterprise Value/EBITDA -4.90

Trading Information

Stock Price History

Beta (5Y Monthly) 1.43
52-Week Change 3-86.80%
S&P500 52-Week Change 3-13.03%
52 Week High 335.5800
52 Week Low 33.8500
50-Day Moving Average 35.4902
200-Day Moving Average 314.7846

Share Statistics

Avg Vol (3 month) 37.42M
Avg Vol (10 day) 37.34M
Shares Outstanding 5224.38M
Implied Shares Outstanding 6N/A
Float 8205.49M
% Held by Insiders 18.74%
% Held by Institutions 195.37%
Shares Short (Jun 14, 2022) 438.01M
Short Ratio (Jun 14, 2022) 45.31
Short % of Float (Jun 14, 2022) 421.69%
Short % of Shares Outstanding (Jun 14, 2022) 416.94%
Shares Short (prior month May 12, 2022) 433.37M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Mar 30, 2022


Profit Margin -130.14%
Operating Margin (ttm)-165.60%

Management Effectiveness

Return on Assets (ttm)-8.74%
Return on Equity (ttm)-34.53%

Income Statement

Revenue (ttm)134.69M
Revenue Per Share (ttm)0.64
Quarterly Revenue Growth (yoy)14.40%
Gross Profit (ttm)59.17M
EBITDA -214.88M
Net Income Avi to Common (ttm)-175.29M
Diluted EPS (ttm)-0.8350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)962.77M
Total Cash Per Share (mrq)4.29
Total Debt (mrq)952.02M
Total Debt/Equity (mrq)129.60
Current Ratio (mrq)16.87
Book Value Per Share (mrq)3.28

Cash Flow Statement

Operating Cash Flow (ttm)-167.1M
Levered Free Cash Flow (ttm)-57.44M